1. AngII infusion induces cardiac hypertrophy, reduces plasma adiponectin levels, inhibits cardiac AdipoR1 expression, and decreases phosphorylation of AMPK and ACC in vivo. Here, ADIPOQ is linked to cardiac hypertrophy.